Article Listing - Shire 3rd-qtr pretax profits leap 67%

SP-PG FOR KAPOSI'S SARCOMA?

23 March 1992

A new experimental compound which could prove useful as a treatment for AIDS patients with Kaposi's sarcoma has been described...

US APPRO OF J&J's HEP C TEST

23 March 1992

The US Food and Drug Administr-ation has licensed Johnson and Johnson's new sensitive blood screening test for the hepatitis C...

UK MARKETING OF MAXEPA

23 March 1992

The only prescription formulation of the fish oil-derived omega-3 fatty acid product Maxepa is to be marketed in the UK...

HYPOLIPIDEMICS INFO

23 March 1992

The Belgian Ministry of Health has issued a transparency sheet on hypolipidemics - the third in its series of comparative...

HOW EC PATENT EXTENSION IS SHAPING UP

23 March 1992

Last week, the Council of the Commission of the European Communities passed to the Europ-ean Parliament its common position on...

FROM A RESEARCH-LED TO A MARKET-DRIVEN FIRM

23 March 1992

The task of pharmaceutical industry management is to achieve the best possible balance between the constant pull of the...

GENZYME CYSTIC FIBROSIS BUY-BACK

23 March 1992

Genzyme Corp and Neozyme say that, subject to completion of a proposed public financing of newly-formed Neozyme II Corp, Gen-zyme...

FRANCE PROBES GLAXO'S IMIGRAN PROMOTION

23 March 1992

The French government has commissioned a report on the pharmaceutical industry's promotional methods, following what it considers to be excessively...

CHILE COMPLETES ITS PATENT LAWS REFORMS

23 March 1992

One of the many features which differentiate the Chilean pharmaceutical sector from that of other Latin American countries is that...

US FDA "SHOULD BAN SPEAKER LISTS"

23 March 1992

Among the views presented to the US Food and Drug Administra-tion on its proposed draft guideline on Drug Company-Sponsored Activities...

Showing 94581-94590 of 95372 articles